Pierre Fabre Medicament - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • ID: 2344729
  • Mergers and Acquisitions Profiles
  • 34 pages
  • MarketLine
  • Pierre Fabre SA
1 of 3
The Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Project Description:

The Pierre Fabre Medicament Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Pierre Fabre Medicament since January 2007.

Scope:

– Provides intelligence on Pierre Fabre Medicament's M&A, strategic partnerships and alliances, capital raising and private equity transactions.
– Detailed reports of various financial transactions undertaken by Pierre Fabre Medicament and its subsidiaries since 2007.
– Information about key financial and legal advisors for Pierre Fabre Medicament's financial deals transactions.
– Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Highlights:

This report includes Pierre Fabre Medicament's contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Pierre Fabre Medicament. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Reasons to Purchase:

– Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
– Form an independent opinion about Pierre Fabre Medicament’s growth strategies through the organic and inorganic activities undertaken since 2007.
– Track your competitors’ business structure and growth strategies.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
COMPANY OVERVIEW AND KEY FACTS

- Mergers and Acquisitions – Deal reports

PARTNERSHIP

- Partnership – Overview

- Partnership – Deal reports

APPENDIX

- Financial Deals Database

- Deal Definition and Methodology

- Datamonitor Professional Services Knowledge Center

LIST OF TABLES

- Pierre Fabre Medicament activity by deal type – volume ( (2011-YTD2015))

- Pierre Fabre Medicament legal advisor ranking by value ($m)

- Pierre Fabre Medicament targets and partners ( (2011-YTD2015))

- Pierre Fabre Medicament partnership volume and value trend (2011-YTD2015)

- Pierre Fabre Medicament partnership trend by key deal type (2011-YTD2015)

LIST OF FIGURES

- Pierre Fabre Medicament activity by deal type - volume (2011-YTD2015)

- Pierre Fabre Medicament partnership volume and value trend (2011-YTD2015)

- Pierre Fabre Medicament partnership trend by key deal type (2011-YTD2015)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll